Eupraxia Pharmaceuticals Inc (EPRX)

Currency in CAD
7.20
-0.13(-1.77%)
Closed·
EPRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EPRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.097.40
52 wk Range
3.078.13
Key Statistics
Bid/Ask
6.70 / 7.36
Prev. Close
7.2
Open
7.4
Day's Range
7.09-7.4
52 wk Range
3.07-8.13
Volume
42.55K
Average Volume (3m)
28.9K
1-Year Change
110.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EPRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.50
Upside
+73.61%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Eupraxia Pharmaceuticals Inc Company Profile

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company’s proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead product candidates include EP-104IAR, which is in Phase III clinical trial for the treatment of unmet medical needs and pain relief for knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

Compare EPRX to Peers and Sector

Metrics to compare
EPRX
Peers
Sector
Relationship
P/E Ratio
−6.4x−2.2x−0.6x
PEG Ratio
−0.590.000.00
Price/Book
−20.4x−0.2x2.6x
Price / LTM Sales
-6.2x3.3x
Upside (Analyst Target)
67.8%242.5%39.0%
Fair Value Upside
Unlock3.3%4.9%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.50
(+73.61% Upside)

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
-0.3329 / -0.2545
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

EPRX Income Statement

People Also Watch

267.28
CLS
+2.24%
193.05
DOL
-0.16%
48.35
IGM
-0.82%
49.11
MX
-1.37%

FAQ

What Stock Exchange Does Eupraxia Pharmaceuticals Trade On?

Eupraxia Pharmaceuticals is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Eupraxia Pharmaceuticals?

The stock symbol for Eupraxia Pharmaceuticals is "EPRX."

What Is the Eupraxia Pharmaceuticals Market Cap?

As of today, Eupraxia Pharmaceuticals market cap is 265.02M.

What Is Eupraxia Pharmaceuticals's Earnings Per Share (TTM)?

The Eupraxia Pharmaceuticals EPS (TTM) is -0.82.

When Is the Next Eupraxia Pharmaceuticals Earnings Date?

Eupraxia Pharmaceuticals will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is EPRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Eupraxia Pharmaceuticals Stock Split?

Eupraxia Pharmaceuticals has split 0 times.

How Many Employees Does Eupraxia Pharmaceuticals Have?

Eupraxia Pharmaceuticals has 33 employees.

What is the current trading status of Eupraxia Pharmaceuticals (EPRX)?

As of 26 Aug 2025, Eupraxia Pharmaceuticals (EPRX) is trading at a price of 7.20, with a previous close of 7.20. The stock has fluctuated within a day range of 7.09 to 7.40, while its 52-week range spans from 3.07 to 8.13.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.